Cargando…

Immune Checkpoint Inhibitor-Induced Diabetes Mellitus: Potential Role of T Cells in the Underlying Mechanism

Immunotherapy is now a recognized treatment option for several types of cancer. However, some cancer patients treated with immune checkpoint inhibitors (ICIs) are subject to immune-related adverse events, including induced diabetes mellitus. The exact role and molecular/genetic action of ICIs in dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mourad, Diane, Azar, Nadim S., Eid, Assaad A., Azar, Sami T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923776/ https://www.ncbi.nlm.nih.gov/pubmed/33672515 http://dx.doi.org/10.3390/ijms22042093

Ejemplares similares

Thyroid Dysfunctions Due to Immune Checkpoint Inhibitors: A Review
por: El Sabbagh, Rawaa, et al.
Publicado: (2020)

Diabetic Nephropathy and COVID-19: The Potential Role of Immune Actors
por: Mourad, Diane, et al.
Publicado: (2021)

COVID-19 and diabetes mellitus: how one pandemic worsens the other
por: Azar, William S., et al.
Publicado: (2020)

Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
por: Ahmadieh, Hala, et al.
Publicado: (2017)

The Role of Vitamin D Deficiency in the Incidence, Progression, and Complications of Type 1 Diabetes Mellitus
por: Chakhtoura, Marlene, et al.
Publicado: (2013)

Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes
por: Ammar, Lama A., et al.
Publicado: (2021)

Osteoporosis in Men with Diabetes Mellitus
por: Issa, Claire, et al.
Publicado: (2011)

Thyroid Disorders and Diabetes Mellitus
por: Hage, Mirella, et al.
Publicado: (2011)

Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease
por: Houeiss, Pamela, et al.
Publicado: (2022)

Immune checkpoint inhibitor–induced diabetes mellitus with pembrolizumab
por: Zand Irani, Anis, et al.
Publicado: (2022)

Immune checkpoint inhibitor-induced diabetes mellitus with nivolumab
por: Zand Irani, Anis, et al.
Publicado: (2023)

Type 2 Diabetes Mellitus, Oral Diabetic Medications, Insulin Therapy, and Overall Breast Cancer Risk
por: Ahmadieh, Hala, et al.
Publicado: (2013)

SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
por: El Mouhayyar, Christopher, et al.
Publicado: (2020)

Magnesium and diabetes mellitus
por: Ghorbani, Ali, et al.
Publicado: (2012)

Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics
por: Refae, Sadal, et al.
Publicado: (2020)

SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism
por: Dia, Batoul, et al.
Publicado: (2023)

Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases
por: Youssef, Natalie, et al.
Publicado: (2021)

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus
por: Liu, Jia, et al.
Publicado: (2022)

Management and control of type 2 diabetes mellitus in Lebanon: Results from the International Diabetes Management Practices Study Wave 6
por: Ahmadieh, Hala, et al.
Publicado: (2019)

SUN-170 Development of Type 1 Diabetes Mellitus on Immune Checkpoint Inhibitor
por: Tsuei, Jessica, et al.
Publicado: (2019)

Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
por: Fujita, Yasunori, et al.
Publicado: (2023)

Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice
por: Cho, Yun Kyung, et al.
Publicado: (2023)

Hypovitaminosis D in Patients with Type 2 Diabetes Mellitus: A Relation to Disease Control and Complications
por: Ahmadieh, Hala, et al.
Publicado: (2013)

Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics
por: Refae, Sadal, et al.
Publicado: (2020)

Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies
por: Ronen, Daniel, et al.
Publicado: (2022)

A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors
por: Deligiorgi, Maria V., et al.
Publicado: (2023)

Antioxidant plants and diabetes mellitus
por: Nasri, Hamid, et al.
Publicado: (2015)

Mechanisms of resistance to immune checkpoint inhibitors
por: Jenkins, Russell W, et al.
Publicado: (2018)

Mechanism of resistance to immune checkpoint inhibitors
por: Pandey, Manu R., et al.
Publicado: (2019)

Mechanisms of resistance to immune checkpoint inhibitors
por: Nagasaki, Joji, et al.
Publicado: (2022)

The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
por: Nardi Agmon, Inbar, et al.
Publicado: (2022)

Infection with Helicobacter pylori may predispose to atherosclerosis: role of inflammation and thickening of intima-media of carotid arteries
por: Aramouni, Karl, et al.
Publicado: (2023)

Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer
por: Ding, Peng, et al.
Publicado: (2022)

Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review
por: de Filette, Jeroen M K, et al.
Publicado: (2019)

Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors
por: Inaba, Hidefumi, et al.
Publicado: (2022)

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020)

Flash Glucose Monitoring and Diabetes Mellitus Induced by Immune Checkpoint Inhibitors: An Approach to Clinical Practice
por: Rodríguez de Vera-Gómez, Pablo, et al.
Publicado: (2022)

Real-world adherence to toxicity management guidelines for immune checkpoint inhibitor-induced diabetes mellitus
por: Shen, Min, et al.
Publicado: (2023)

Acquired Resistance to Immune Checkpoint Blockades: The Underlying Mechanisms and Potential Strategies
por: Zhou, Binghan, et al.
Publicado: (2021)

Seasonal variation of vitamin D and HbA(1c) levels in patients with type 1 diabetes mellitus in the Middle East
por: El Baba, Khaled, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ctb5a4u7h2g0b5fsthb6v7t2c0